Fluoroethyltyrosine for Evaluation of Intracranial Neoplasms

Clinical trial NCT04044937 · COMPLETED

Trial details

NCT number: NCT04044937
Sponsor: Thomas Hope
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Intracranial Neoplasm Low Grade Glioma Recurrent Glioblastoma Recurrent World Health Organization (WHO) Grade II Glioma Recurrent WHO Grade III Glioma

Start date: 2018-10-29
Primary completion: 2024-03-31
Enrollment: 143

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.